A Tale of Two Pathways: Renewing the Promise of Anti-CD40L Blockade.

Thomson, A W; Ezzelarab, M B

Thomson, A W; Ezzelarab, M B.

Afiliación

Thomson AW; Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Ezzelarab MB; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Am J Transplant ; 17(5): 1156-1157, 2017 05.

Article en En | MEDLINE | ID: mdl-28141921

Asunto(s)

Ligando de CD40; Trasplante de Riñón; Animales; Rechazo de Injerto; Supervivencia de Injerto; Primates

Palabras clave

animal models: nonhuman primate; costimulation; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: costimulation molecule specific; immunosuppressant; immunosuppression/immune modulation; kidney transplantation/nephrology; translational research/science

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Ligando de CD40 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Panamá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google